Breast Cancer Research & Treatment Issues Research Articles in September 2024 Edition
August 05, 2024
August 05, 2024
BASEL, Switzerland, Aug. 5 -- Breast Cancer Research and Treatment, a peer-reviewed journal, published research articles on the following topics in its September 2024 edition (Vol. 207, Issue 2):
* Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study
* The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene . . .
* Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study
* The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene . . .